메뉴 건너뛰기




Volumn 5, Issue 1, 2010, Pages 20-24

Bivalirudin: Alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia

Author keywords

Bivalirudin; Cardiopulmonary bypass; Heparin induced thrombocytopenia

Indexed keywords

HEPARIN; HIRULOG; THROMBIN INHIBITOR;

EID: 77951103491     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489010790192674     Document Type: Review
Times cited : (16)

References (37)
  • 1
    • 39149093025 scopus 로고    scopus 로고
    • Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT)
    • Baldwin ZK, Spitzer AL, Ng VL, Harken AH. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT). Surgery 2008; 143(3): 305-312.
    • (2008) Surgery , vol.143 , Issue.3 , pp. 305-312
    • Baldwin, Z.K.1    Spitzer, A.L.2    Ng, V.L.3    Harken, A.H.4
  • 2
    • 0037610516 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia and cardiac surgery
    • Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76: 638-648.
    • (2003) Ann Thorac Surg , vol.76 , pp. 638-648
    • Warkentin, T.E.1    Greinacher, A.2
  • 4
    • 0029878458 scopus 로고    scopus 로고
    • Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
    • Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996; 92(4): 954-959.
    • (1996) Br J Haematol , vol.92 , Issue.4 , pp. 954-959
    • Amiral, J.1    Wolf, M.2    Fischer, A.3    Boyer-Neumann, C.4    Vissac, A.5    Meyer, D.6
  • 5
    • 0038657918 scopus 로고    scopus 로고
    • The pathophysiology of immune-mediated heparin-induced thrombocytopenia
    • Reilly RF. The pathophysiology of immune-mediated heparin-induced thrombocytopenia. Semin Dial 2003; 16: 54-60.
    • (2003) Semin Dial , vol.16 , pp. 54-60
    • Reilly, R.F.1
  • 6
    • 1242297625 scopus 로고    scopus 로고
    • Treatment of heparin-induced thrombocytopenia: A critical review
    • Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 2004; 164 (4): 361-369.
    • (2004) Arch Intern Med , vol.164 , Issue.4 , pp. 361-369
    • Hirsh, J.1    Heddle, N.2    Kelton, J.G.3
  • 7
    • 19644398319 scopus 로고    scopus 로고
    • When heparins promote thrombosis: Review of heparin-induced thrombocytopenia
    • Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 2005; 111(20): 2671-2683.
    • (2005) Circulation , vol.111 , Issue.20 , pp. 2671-2683
    • Jang, I.K.1    Hursting, M.J.2
  • 8
    • 66649117716 scopus 로고    scopus 로고
    • Heparin-induced thrombo-cytopenia. A contemporary clinical approach to diagnosis and management
    • Shantsila E, Lip GY, Chong BH. Heparin-induced thrombo-cytopenia. A contemporary clinical approach to diagnosis and management. Chest 2009; 135(6): 1651-1664.
    • (2009) Chest , vol.135 , Issue.6 , pp. 1651-1664
    • Shantsila, E.1    Lip, G.Y.2    Chong, B.H.3
  • 9
    • 10944230701 scopus 로고    scopus 로고
    • Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors
    • Gurm HS, Bhatt DL. Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors. Am Heart J 2005; 149(1S): S43-S53.
    • (2005) Am Heart J , vol.149 , Issue.1 S
    • Gurm, H.S.1    Bhatt, D.L.2
  • 10
    • 0036161816 scopus 로고    scopus 로고
    • Bivalirudin: A direct thrombin inhibitor
    • Gladwell TD. Bivalirudin: A direct thrombin inhibitor. Clin Ther 2002; 24(1): 38-58.
    • (2002) Clin Ther , vol.24 , Issue.1 , pp. 38-58
    • Gladwell, T.D.1
  • 11
    • 0031729548 scopus 로고    scopus 로고
    • Direct thrombin inhibitors for treatment of arterial thrombosis: Potential differences between bivalirudin and hirudin
    • Bates SM, Weitz JI. Direct thrombin inhibitors for treatment of arterial thrombosis: Potential differences between bivalirudin and hirudin. Am J Cardiol 1998; 82(Suppl 1): 12P-18P.
    • (1998) Am J Cardiol , vol.82 , Issue.SUPPL. 1
    • Bates, S.M.1    Weitz, J.I.2
  • 13
    • 0025357208 scopus 로고
    • Platelet functions in recombinant hirudin-anticoagulated blood
    • Glusa E, Markwardt F. Platelet functions in recombinant hirudin-anticoagulated blood. Haemostasis 1990; 20(2): 112-118.
    • (1990) Haemostasis , vol.20 , Issue.2 , pp. 112-118
    • Glusa, E.1    Markwardt, F.2
  • 14
    • 63849185591 scopus 로고    scopus 로고
    • What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    • Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, et al. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention? Blood Coagul Fibrinolysis 2008; 19(5): 401-404.
    • (2008) Blood Coagul Fibrinolysis , vol.19 , Issue.5 , pp. 401-404
    • Cruz-Gonzalez, I.1    Sanchez-Ledesma, M.2    Osakabe, M.3
  • 15
    • 0035853125 scopus 로고    scopus 로고
    • Recombinant hirudin in clinical practice: Focus on lepirudin
    • Greinacher A, Lubenow N. Recombinant hirudin in clinical practice: focus on lepirudin. Circulation 2001; 103(10): 1479-1484.
    • (2001) Circulation , vol.103 , Issue.10 , pp. 1479-1484
    • Greinacher, A.1    Lubenow, N.2
  • 16
    • 0242381320 scopus 로고    scopus 로고
    • Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia
    • Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation 2003; 108(17): 2062-2065.
    • (2003) Circulation , vol.108 , Issue.17 , pp. 2062-2065
    • Greinacher, A.1    Lubenow, N.2    Eichler, P.3
  • 17
    • 0029103184 scopus 로고
    • Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators
    • Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med 1995; 333: 764-769.
    • (1995) N Engl J Med , vol.333 , pp. 764-769
    • Bittl, J.A.1    Strony, J.2    Brinker, J.A.3
  • 18
    • 0031761307 scopus 로고    scopus 로고
    • A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina
    • Hirulog Angioplasty Study Investigators
    • Bittl JA, Feit F. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators. Am J Cardiol 1998; 82: 43P-49P.
    • (1998) Am J Cardiol , vol.82
    • Bittl, J.A.1    Feit, F.2
  • 19
    • 1442300128 scopus 로고    scopus 로고
    • Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery
    • Merry AF, Raudkivi PJ, Middleton NG, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 925-931.
    • (2004) Ann Thorac Surg , vol.77 , pp. 925-931
    • Merry, A.F.1    Raudkivi, P.J.2    Middleton, N.G.3
  • 20
    • 0036898982 scopus 로고    scopus 로고
    • Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery
    • Vasquez JC, Vichiendilokkul A, Mahmood S, Baciewicz A. Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery. Ann Thorac Surg 2002; 74: 2177-2179.
    • (2002) Ann Thorac Surg , vol.74 , pp. 2177-2179
    • Vasquez, J.C.1    Vichiendilokkul, A.2    Mahmood, S.3    Baciewicz, A.4
  • 21
    • 0142094653 scopus 로고    scopus 로고
    • Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia
    • Gordon G. Rastegar H, Schumann R, Deiss-Shrem J, Denman W. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothoracic Vasc Anesth 2003; 17(5): 632-635.
    • (2003) J Cardiothoracic Vasc Anesth , vol.17 , Issue.5 , pp. 632-635
    • Gordon, G.1    Rastegar, H.2    Schumann, R.3    Deiss-Shrem, J.4    Denman, W.5
  • 22
    • 0037232493 scopus 로고    scopus 로고
    • Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass
    • Davis Z, Anderson R, Short D, et al. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Ann Thorac Surg 2003; 75: 264-265.
    • (2003) Ann Thorac Surg , vol.75 , pp. 264-265
    • Davis, Z.1    Anderson, R.2    Short, D.3
  • 24
    • 32044444044 scopus 로고    scopus 로고
    • Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin induced thrombocytopenia
    • Wasowicz M, Vegas A, Borger MA, Harwood S. Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin induced thrombocytopenia. Can J Anesth 2005; 52(10); 1093-1098.
    • (2005) Can J Anesth , vol.52 , Issue.10 , pp. 1093-1098
    • Wasowicz, M.1    Vegas, A.2    Borger, M.A.3    Harwood, S.4
  • 25
    • 20544476499 scopus 로고    scopus 로고
    • Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patient with potential heparin-induced thrombocytopenia
    • Dyke CM, Koster A, Veale JJ, Maier GW, McNiff T, Levy JH. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patient with potential heparin-induced thrombocytopenia. Ann Thorac Surg 2005; 80: 299-303.
    • (2005) Ann Thorac Surg , vol.80 , pp. 299-303
    • Dyke, C.M.1    Koster, A.2    Veale, J.J.3    Maier, G.W.4    McNiff, T.5    Levy, J.H.6
  • 26
    • 33846519559 scopus 로고    scopus 로고
    • Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial
    • Koster A, Dyke CM, Aldea G, et al. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial. Ann Thorac Surg 2007; 83: 572-577.
    • (2007) Ann Thorac Surg , vol.83 , pp. 572-577
    • Koster, A.1    Dyke, C.M.2    Aldea, G.3
  • 27
    • 10744225946 scopus 로고    scopus 로고
    • Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting
    • Koster A, Spiess B, Chew DP, et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004; 93: 356-359.
    • (2004) Am J Cardiol , vol.93 , pp. 356-359
    • Koster, A.1    Spiess, B.2    Chew, D.P.3
  • 28
    • 33644586875 scopus 로고    scopus 로고
    • A comparison of bivalirudin to heparin with protamine in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study
    • Dyke CM, Smedira NG, Koster A, et al. A comparison of bivalirudin to heparin with protamine in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study. J Thorac Cardiovasc Surg 2006; 131: 533-539.
    • (2006) J Thorac Cardiovasc Surg , vol.131 , pp. 533-539
    • Dyke, C.M.1    Smedira, N.G.2    Koster, A.3
  • 29
    • 0037302802 scopus 로고    scopus 로고
    • Bivalirudin monitored with ecarin clotting time for anticoagulation during cardiopulmonary bypass
    • Koster A, Chew D, Grundel M, Bauer M, Kuppe H, Spiess BD. Bivalirudin monitored with ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg 2003; 96: 383-386.
    • (2003) Anesth Analg , vol.96 , pp. 383-386
    • Koster, A.1    Chew, D.2    Grundel, M.3    Bauer, M.4    Kuppe, H.5    Spiess, B.D.6
  • 30
    • 0027209030 scopus 로고
    • Use of a direct antithrombin, Hirulog, in place of heparin during coronary angioplasty
    • Topol EJ, Bonan R, Jewitt D, et al. Use of a direct antithrombin, Hirulog, in place of heparin during coronary angioplasty. Circulation 1993; 87: 1622-1629.
    • (1993) Circulation , vol.87 , pp. 1622-1629
    • Topol, E.J.1    Bonan, R.2    Jewitt, D.3
  • 31
    • 0036021209 scopus 로고    scopus 로고
    • Bivalirudin: A direct thrombin inhibitor for percutaneous transluminal coronary angioplasty
    • Wiggins BS, Spinler S, Wittkowsky AK, Stringer KA. Bivalirudin: A direct thrombin inhibitor for percutaneous transluminal coronary angioplasty. Pharmacotherapy 2002; 22(8): 1007-1018.
    • (2002) Pharmacotherapy , vol.22 , Issue.8 , pp. 1007-1018
    • Wiggins, B.S.1    Spinler, S.2    Wittkowsky, A.K.3    Stringer, K.A.4
  • 32
    • 33645686878 scopus 로고    scopus 로고
    • Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia
    • Dang CH, Durkalski VL, Nappi JM. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy 2006; 26(4): 461-468.
    • (2006) Pharmacotherapy , vol.26 , Issue.4 , pp. 461-468
    • Dang, C.H.1    Durkalski, V.L.2    Nappi, J.M.3
  • 34
    • 77951103625 scopus 로고    scopus 로고
    • US20080051558
    • Zhou, Y.: US20080051558 (2008).
    • (2008)
    • Zhou, Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.